» Articles » PMID: 9825380

Long-term Follow-up After Right Atrial Radiofrequency Catheter Treatment of Paroxysmal Atrial Fibrillation

Overview
Date 1998 Nov 24
PMID 9825380
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Catheter ablation of paroxysmal atrial fibrillation using long linear lesions in the right atrium is still under investigation, and its long-term follow-up is unknown.

Methods: Thirty-six men and nine women (aged 51 +/- 12 years) with symptomatic daily episodes of AF for 6 +/- 5 years despite the use of 4.7 +/- 1.5 antiarrhythmic drugs were studied between July 1994 and January 1996. Progressively longer ablation lines were performed in 3 groups of 15 consecutive patients each, using a 14-electrode catheter or a single-electrode dragging technique. Success was defined as atrial fibrillation elimination or recurrence for no longer than 6 hours over 3 months of observation. Patients who had fewer than 6 hours of atrial fibrillation per month were considered "improved." Medium- (11 +/- 4 months) and long-term (26 +/- 5 months) results were assessed clinically from a patient's diary and from Holter recordings.

Results: After a follow-up of 11 months, 24 patients had a favorable result of the ablation procedure with or without additional antiarrhythmic drug therapy, representing 53% of the original cohort. After 26 +/- 5 months of follow-up, these successful results were reduced to 17 patients (37%).

Conclusions: After linear atrial ablation, a significant long-term attrition of arrhythmia-free patients was observed. This may be due to a combination of disease progression, incomplete linear block, and ineffective ablation of arrhythmogenic triggers.

Citing Articles

Atrial fibrillation ablation strategies and technologies: past, present, and future.

Buist T, Zipes D, Elvan A Clin Res Cardiol. 2020; 110(6):775-788.

PMID: 33089361 DOI: 10.1007/s00392-020-01751-5.


2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Calkins H, Hindricks G, Cappato R, Kim Y, Saad E, Aguinaga L Europace. 2017; 20(1):e1-e160.

PMID: 29016840 PMC: 5834122. DOI: 10.1093/europace/eux274.


2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Calkins H, Hindricks G, Cappato R, Kim Y, Saad E, Aguinaga L Heart Rhythm. 2017; 14(10):e275-e444.

PMID: 28506916 PMC: 6019327. DOI: 10.1016/j.hrthm.2017.05.012.


Left Atrial Fibrosis: Role in Atrial Fibrillation Pathophysiology and Treatment Outcomes.

Spragg D J Atr Fibrillation. 2017; 5(6):810.

PMID: 28496835 PMC: 5153181. DOI: 10.4022/jafib.810.


Collateral Damage During Ablation of Atrial Fibrillation - Lessons Learnt in the Past Decade.

Spragg D J Atr Fibrillation. 2017; 4(5):478.

PMID: 28496719 PMC: 5153008. DOI: 10.4022/jafib.478.